欢迎来到天天文库
浏览记录
ID:55057902
大小:207.30 KB
页数:3页
时间:2020-05-08
《介入治疗对胰腺癌乙型肝炎病毒感染患者的疗效分析-论文.pdf》由会员上传分享,免费在线阅读,更多相关内容在行业资料-天天文库。
1、中华医院感染学杂志2014年第24卷第4期ChinJNosocomiolVo1.24No.42014·959·doi:10.11816/cn.ni.2014—135467·论著介入治疗对胰腺癌乙型肝炎病毒感染患者的疗效分析彭科,赵渝,凌康,陈思宇,曾秋,钟巍(1.重庆医科大学附属第一医院血管外科2.肝胆外科,重庆400016)摘要:目的分析介入治疗对胰腺癌乙型肝炎病毒(HBV)感染患者的疗效,为改善患者的预后提供理论依据。方法选取医院2010年3月一2011年3月86例胰腺癌HBV感染患者,按照随机数字表法分为介入组及手术组,每组各43例,分别使用介入治
2、疗及手术治疗,比较两组患者的临床疗效,并进行两年的随访,观察其6个月、1年及两年生存率,采用SPSS13.0软件对数据进行统计分析。结果治疗总有效率介入组为67.4、手术组为37.2,介入组治疗效果显著优于手术组;不良反应发生率介入组为32.6、手术组为11.6,介入组不良反应发生率显著高于手术组;治疗后介入组患者sTNFR—IV、IAP等指标显著低于手术组,差异有统计学意义(P<0.05);6个月、1、2年生存率介入组分别为97.7、83.7、34.9,均显著高于手术组的88.4、67.4、16.3,差异有统计学意义(P3、阻止胰腺癌肿瘤血管营养供给,影响肿瘤的浸润和转移,且能够显著改善患者的自身免疫功能,降低HBV感染带来的胰腺损伤,有利于保证其生存质量,同时,介入治疗较传统化疗具有更高的安全性和局部药物浓度,创伤小、操作简便,是临床治疗中晚期胰腺癌的有效方式。关键词:介入治疗;胰腺癌;疗效;安全性中图分类号:R512.62文献标识码:A文章编号:1005—4529(2014)04—0959—03ClinicalefficacyofinterventionaltherapyinpancreaticcancerpatientswithhepatitisBvirusinfec4、tionPENGKe,ZHAOYu,LINGKang,CHENSi-yu,ZENGQiu,ZHONGWei(FirstAffiliatedHospitalofChongqingMedicalUniversity,Chongqing400016,China)Abstract:OBJECTIVEToanalyzetheclinicalefficacyofinterventionaltherapyinthepancreaticcancerpatientswithhepatitisBvirus(HBV)infectionsoastoprovidetheoreti5、calbasisforimprovingtheprognosisofpatients.METHODSTotally86casesofpancreaticcanerpatientswithHBVinfection,whoweretreatedinthehospitalfromMar2010toMar2011,wereenrolledinthestudyandrandomlydividedintotheinterventiongroupandthesurgerygroup,with43casesineach,thentheinterventionalther6、apyandthesurgicalprocedureswererespectivelyperformed,theclinicalefficacywascomparedbetweenthetwogroups,atwo—yearfollow—upwasconducted,thesurvivalratesatsixmonths,1year,andtwoyearswereobserved,andthestatisticalanalysiswasperformedwiththeuseofSPSS13.0software.RESULTSThetotaleffecti7、verateoftreatmentwas67.4%intheinterventiongroup,37.2inthesurgerygroup,thetherapeuticeffectoftheinterventiongroupwassignificantlybetterthanthatofthesurgerygroup;theincidenceofadversereactionsoftheinterventiongroupwas32.6,significantlyhigherthan11.6ofthesurgerygroup;thelevelsofthei8、ndicatorssuchassTNFR—IVandIAPweresignifi
3、阻止胰腺癌肿瘤血管营养供给,影响肿瘤的浸润和转移,且能够显著改善患者的自身免疫功能,降低HBV感染带来的胰腺损伤,有利于保证其生存质量,同时,介入治疗较传统化疗具有更高的安全性和局部药物浓度,创伤小、操作简便,是临床治疗中晚期胰腺癌的有效方式。关键词:介入治疗;胰腺癌;疗效;安全性中图分类号:R512.62文献标识码:A文章编号:1005—4529(2014)04—0959—03ClinicalefficacyofinterventionaltherapyinpancreaticcancerpatientswithhepatitisBvirusinfec
4、tionPENGKe,ZHAOYu,LINGKang,CHENSi-yu,ZENGQiu,ZHONGWei(FirstAffiliatedHospitalofChongqingMedicalUniversity,Chongqing400016,China)Abstract:OBJECTIVEToanalyzetheclinicalefficacyofinterventionaltherapyinthepancreaticcancerpatientswithhepatitisBvirus(HBV)infectionsoastoprovidetheoreti
5、calbasisforimprovingtheprognosisofpatients.METHODSTotally86casesofpancreaticcanerpatientswithHBVinfection,whoweretreatedinthehospitalfromMar2010toMar2011,wereenrolledinthestudyandrandomlydividedintotheinterventiongroupandthesurgerygroup,with43casesineach,thentheinterventionalther
6、apyandthesurgicalprocedureswererespectivelyperformed,theclinicalefficacywascomparedbetweenthetwogroups,atwo—yearfollow—upwasconducted,thesurvivalratesatsixmonths,1year,andtwoyearswereobserved,andthestatisticalanalysiswasperformedwiththeuseofSPSS13.0software.RESULTSThetotaleffecti
7、verateoftreatmentwas67.4%intheinterventiongroup,37.2inthesurgerygroup,thetherapeuticeffectoftheinterventiongroupwassignificantlybetterthanthatofthesurgerygroup;theincidenceofadversereactionsoftheinterventiongroupwas32.6,significantlyhigherthan11.6ofthesurgerygroup;thelevelsofthei
8、ndicatorssuchassTNFR—IVandIAPweresignifi
此文档下载收益归作者所有